The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of baseline and early changes of circulating-free (cf) and circulating tumor (ct) DNA in the neoadjuvant (NA) setting of early stage colon cancer (CC).
 
Giacomo Bregni
No Relationships to Disclose
 
Chiara Senti
No Relationships to Disclose
 
Caroline Vandeputte
No Relationships to Disclose
 
Elena Acedo Reina
No Relationships to Disclose
 
Paraskevas Gkolfakis
No Relationships to Disclose
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Philippe Vergauwe
No Relationships to Disclose
 
Marc Van Den Eynde
Consulting or Advisory Role - amgen (Inst); Lilly (Inst); Merck KGaA (Inst); SERVIER (Inst)
Research Funding - Merck KGaA (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen (Inst); Roche (Inst)
 
Jos Janssens
No Relationships to Disclose
 
Gauthier Demolin
No Relationships to Disclose
 
Stephane Holbrechts
No Relationships to Disclose
 
Marylene Clausse
No Relationships to Disclose
 
Thierry De Grez
No Relationships to Disclose
 
Lionel A. D'Hondt
No Relationships to Disclose
 
Karen Paula Geboes
No Relationships to Disclose
 
Tatiana Besse-Hammer
No Relationships to Disclose
 
Francoise Rothe
No Relationships to Disclose
 
Patrick Flamen
No Relationships to Disclose
 
Alain Hendlisz
No Relationships to Disclose
 
Francesco Sclafani
Consulting or Advisory Role - Bayer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly